Serum Inflammation Biomarkers and Micronutrient Levels in Nigerian Breast Cancer Patients with Different Hormonal Immunohistochemistry Status

Background: The importance and relevance of serum inflammation biomarkers and DNA methylation-dependent micronutrients in breast tumorigenesis is gaining wider acceptance. However, the association of serum inflammation biomarkers and micronutrient status with expression of estrogen receptors (ER),...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ganiyu Olatunbosun Arinola, Fabian Victory Edem, Abayomi Benjamin Odetunde, Christopher Olusola Olopade, Olufunmilayo Ibironke Olopade
Formato:	article
Lenguaje:	EN
Publicado:	Kaviani Breast Disease Institute 2021
Materias:	Cytokines Breast cancer Inflammation Methylation Micronutrients Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/a9fc2cfbb8d94cb6bed525bc11ff8819
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:a9fc2cfbb8d94cb6bed525bc11ff8819
record_format	dspace
spelling	oai:doaj.org-article:a9fc2cfbb8d94cb6bed525bc11ff88192021-12-04T02:18:51ZSerum Inflammation Biomarkers and Micronutrient Levels in Nigerian Breast Cancer Patients with Different Hormonal Immunohistochemistry Status10.32768/abc.202184329-3372383-0433https://doaj.org/article/a9fc2cfbb8d94cb6bed525bc11ff88192021-10-01T00:00:00Zhttps://www.archbreastcancer.com/index.php/abc/article/view/449https://doaj.org/toc/2383-0433 Background: The importance and relevance of serum inflammation biomarkers and DNA methylation-dependent micronutrients in breast tumorigenesis is gaining wider acceptance. However, the association of serum inflammation biomarkers and micronutrient status with expression of estrogen receptors (ER), progesterone receptors (PR) and human epidermal growth factor receptor-2 (HER-2) by the tumor has not been investigated in Nigerian breast cancer patients. The objective of this study was to determine the levels of serum biomarkers of inflammation [Homocysteine, Nitric Oxide (NO), Hydrogen peroxide (H2O2), Myeloperoxidase (MPO), Tumor necrosis factor alpha (TNF-α), Interleukins 6 and 8 (IL-6 and IL-8)] and DNA methylation-dependent micronutrients [Zinc (Zn), Folic acid, Vitamin B6 and B12] in breast cancer patients with different hormone receptors (ER, PR and HER-2). Methods: One hundred and fifteen women (80 with breast cancer and 35 controls) were randomly recruited for this study. Serum levels of homocysteine, folic acid, vitamins B6, vitamin B12, TNF-α, IL-6 and IL-8) were analyzed using ELISA, while the levels of NO, MPO, H2O2 and Zn were determined using spectrophotometer in patients with breast cancer and control subjects without breast cancer as well as breast cancer patients with ER, PR and HER-2 expression were determined. Results: The results showed that mean serum levels of IL-6 (p=0.002), IL-8 (p=0.018) and H2O2 (p=0.000) were significantly increased while TNF-α (p=0.014) and NO levels (p=0.044) were significantly decreased in breast cancer patients compared to healthy controls. However, there were no statistically significant differences in the levels of Zn, homocysteine, Vitamin B6, Vitamin B12 and MPO in breast cancer patients and controls. Furthermore, the levels of serum inflammatory biomarkers and methylation-dependent micronutrients were similar in breast cancer patients with HER-2, ER and PR expression. Conclusion: Systemic inflammation exists in breast cancer patients but the inflammation biomarkers and methylation-dependent micronutrients did not differ among breast cancer patients with PR, ER and HER-2 expression. Ganiyu Olatunbosun ArinolaFabian Victory EdemAbayomi Benjamin OdetundeChristopher Olusola OlopadeOlufunmilayo Ibironke OlopadeKaviani Breast Disease InstitutearticleCytokinesBreast cancerInflammationMethylation MicronutrientsNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENArchives of Breast Cancer (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Cytokines Breast cancer Inflammation Methylation Micronutrients Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
spellingShingle	Cytokines Breast cancer Inflammation Methylation Micronutrients Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Ganiyu Olatunbosun Arinola Fabian Victory Edem Abayomi Benjamin Odetunde Christopher Olusola Olopade Olufunmilayo Ibironke Olopade Serum Inflammation Biomarkers and Micronutrient Levels in Nigerian Breast Cancer Patients with Different Hormonal Immunohistochemistry Status
description	Background: The importance and relevance of serum inflammation biomarkers and DNA methylation-dependent micronutrients in breast tumorigenesis is gaining wider acceptance. However, the association of serum inflammation biomarkers and micronutrient status with expression of estrogen receptors (ER), progesterone receptors (PR) and human epidermal growth factor receptor-2 (HER-2) by the tumor has not been investigated in Nigerian breast cancer patients. The objective of this study was to determine the levels of serum biomarkers of inflammation [Homocysteine, Nitric Oxide (NO), Hydrogen peroxide (H2O2), Myeloperoxidase (MPO), Tumor necrosis factor alpha (TNF-α), Interleukins 6 and 8 (IL-6 and IL-8)] and DNA methylation-dependent micronutrients [Zinc (Zn), Folic acid, Vitamin B6 and B12] in breast cancer patients with different hormone receptors (ER, PR and HER-2). Methods: One hundred and fifteen women (80 with breast cancer and 35 controls) were randomly recruited for this study. Serum levels of homocysteine, folic acid, vitamins B6, vitamin B12, TNF-α, IL-6 and IL-8) were analyzed using ELISA, while the levels of NO, MPO, H2O2 and Zn were determined using spectrophotometer in patients with breast cancer and control subjects without breast cancer as well as breast cancer patients with ER, PR and HER-2 expression were determined. Results: The results showed that mean serum levels of IL-6 (p=0.002), IL-8 (p=0.018) and H2O2 (p=0.000) were significantly increased while TNF-α (p=0.014) and NO levels (p=0.044) were significantly decreased in breast cancer patients compared to healthy controls. However, there were no statistically significant differences in the levels of Zn, homocysteine, Vitamin B6, Vitamin B12 and MPO in breast cancer patients and controls. Furthermore, the levels of serum inflammatory biomarkers and methylation-dependent micronutrients were similar in breast cancer patients with HER-2, ER and PR expression. Conclusion: Systemic inflammation exists in breast cancer patients but the inflammation biomarkers and methylation-dependent micronutrients did not differ among breast cancer patients with PR, ER and HER-2 expression.
format	article
author	Ganiyu Olatunbosun Arinola Fabian Victory Edem Abayomi Benjamin Odetunde Christopher Olusola Olopade Olufunmilayo Ibironke Olopade
author_facet	Ganiyu Olatunbosun Arinola Fabian Victory Edem Abayomi Benjamin Odetunde Christopher Olusola Olopade Olufunmilayo Ibironke Olopade
author_sort	Ganiyu Olatunbosun Arinola
title	Serum Inflammation Biomarkers and Micronutrient Levels in Nigerian Breast Cancer Patients with Different Hormonal Immunohistochemistry Status
title_short	Serum Inflammation Biomarkers and Micronutrient Levels in Nigerian Breast Cancer Patients with Different Hormonal Immunohistochemistry Status
title_full	Serum Inflammation Biomarkers and Micronutrient Levels in Nigerian Breast Cancer Patients with Different Hormonal Immunohistochemistry Status
title_fullStr	Serum Inflammation Biomarkers and Micronutrient Levels in Nigerian Breast Cancer Patients with Different Hormonal Immunohistochemistry Status
title_full_unstemmed	Serum Inflammation Biomarkers and Micronutrient Levels in Nigerian Breast Cancer Patients with Different Hormonal Immunohistochemistry Status
title_sort	serum inflammation biomarkers and micronutrient levels in nigerian breast cancer patients with different hormonal immunohistochemistry status
publisher	Kaviani Breast Disease Institute
publishDate	2021
url	https://doaj.org/article/a9fc2cfbb8d94cb6bed525bc11ff8819
work_keys_str_mv	AT ganiyuolatunbosunarinola seruminflammationbiomarkersandmicronutrientlevelsinnigerianbreastcancerpatientswithdifferenthormonalimmunohistochemistrystatus AT fabianvictoryedem seruminflammationbiomarkersandmicronutrientlevelsinnigerianbreastcancerpatientswithdifferenthormonalimmunohistochemistrystatus AT abayomibenjaminodetunde seruminflammationbiomarkersandmicronutrientlevelsinnigerianbreastcancerpatientswithdifferenthormonalimmunohistochemistrystatus AT christopherolusolaolopade seruminflammationbiomarkersandmicronutrientlevelsinnigerianbreastcancerpatientswithdifferenthormonalimmunohistochemistrystatus AT olufunmilayoibironkeolopade seruminflammationbiomarkersandmicronutrientlevelsinnigerianbreastcancerpatientswithdifferenthormonalimmunohistochemistrystatus
_version_	1718373048073060352

Serum Inflammation Biomarkers and Micronutrient Levels in Nigerian Breast Cancer Patients with Different Hormonal Immunohistochemistry Status

Ejemplares similares